Furthermore, detailed cardiac analyses of the rodent model for adenine-induced tubulointerstitial nephropathy, where serum FGF23 levels are highly elevated (182) and appear to positively correlate with cardiac hypertrophy (183), should help to further determine a causative role of FGF23 in uremic cardiomyopathy. This evidence concerns the gene FGF23 and cardiac hypertrophy.